These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30268857)

  • 21. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    Khan S; Warade S; Singhavi DJ
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous monitoring of circadian variations in intraocular pressure by telemetry system throughout a 12-week treatment with timolol maleate in rabbits.
    Akaishi T; Ishida N; Shimazaki A; Hara H; Kuwayama Y
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):436-44. PubMed ID: 16386085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of O/W nanoemulsions for ophthalmic administration of timolol.
    Gallarate M; Chirio D; Bussano R; Peira E; Battaglia L; Baratta F; Trotta M
    Int J Pharm; 2013 Jan; 440(2):126-34. PubMed ID: 23078859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
    Tighsazzadeh M; Mitchell JC; Boateng JS
    Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
    Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
    AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lollipop-Inspired Multilayered Drug Delivery Hydrogel for Dual Effective, Long-Term, and NIR-Defined Glaucoma Treatment.
    Wang F; Song Y; Huang J; Wu B; Wang Y; Pang Y; Zhang W; Zhu Z; Ma F; Wang X; Zhang X
    Macromol Biosci; 2021 Nov; 21(11):e2100202. PubMed ID: 34405963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
    Shokry M; Hathout RM; Mansour S
    Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M; Mahmoodzadeh M; Farrahi F
    AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.
    Kaur IP; Aggarwal D; Singh H; Kakkar S
    Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1467-72. PubMed ID: 20437246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication.
    Hathout RM; Gad HA; Abdel-Hafez SM; Nasser N; Khalil N; Ateyya T; Amr A; Yasser N; Nasr S; Metwally AA
    Int J Pharm; 2019 Feb; 556():192-199. PubMed ID: 30553005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.
    Fukuda M; Sasaki H
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension.
    Shibuya T; Kashiwagi K; Tsukahara S
    Ophthalmologica; 2003; 217(1):31-8. PubMed ID: 12566870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models.
    Akaishi T; Shimazaki A; Tonouchi A; Ueda K; Miyawaki N; Kawazu K
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):518-24. PubMed ID: 26325164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits.
    Loftsson T; Thorisdóttir S; Fridriksdóttir H; Stefánsson E
    Acta Ophthalmol; 2010 May; 88(3):337-41. PubMed ID: 19432862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
    Urtti A; Rouhiainen H; Kaila T; Saano V
    Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.